<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
<channel>
  <title>Nyheter om: Advance ADHD Drug Development Using AI Modelling</title>
  <link>https://www.pressen.se/</link>
  <description>På Pressen.se kan du söka efter artiklar i svenska medier.</description>
    <pubDate>Fri, 18 Aug 2023 14:26:23 GMT</pubDate>
  <item>
    <title>3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling</title>
    <pubDate>Fri, 18 Aug 2023 14:26:23 GMT</pubDate>
    <link>https://www.pressen.se/906097845.html</link>
    <description>Reykjavik-based drug discovery company, 3Z, and Germany/US-based causal AI firm, biotx.ai, have joined forces in a strategic partnership aimed at revolutionizing ADHD drug development. By leveraging advanced AI modelling techniques, the collaboration seeks to bridge the gap between animal studies and human clinical trials, enabling a more efficient and accurate translation of promising therapeutics..</description>
    <source>DI</source>
  </item>


</channel>
</rss><!-- CR: cache is set: Sidan laddades på 0.46229910850525 s -->